Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.160
+0.090 (2.93%)
At close: Jul 20, 2026, 4:00 PM EDT
3.150
-0.010 (-0.32%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $12.05 million as of July 20, 2026. Its market cap has increased by 308.23% in one year.
Market Cap
12.05M
Enterprise Value
4.46M
1-Year Change
308.23%
Ranking
Category
Stock Price
$3.16
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $12.05M, a decrease of -96.27%. That is a compound annual growth rate of -51.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 12.05M | 754.60% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 12.82M |
| Intensity Therapeutics | 12.70M |
| Phio Pharmaceuticals | 12.55M |
| IN8bio | 12.41M |
| GT Biopharma | 12.30M |
| BioLineRx | 12.07M |
| Exicure | 12.05M |
| Lunai Bioworks | 11.97M |